Related Experiment Video
Updated: Feb 27, 2026

09:06
Efficient and Site-specific Antibody Labeling by Strain-promoted Azide-alkyne Cycloaddition
Published on: December 23, 2016
22.5K
Adapting the Glaser Reaction for Bioconjugation: Robust Access to Structurally Simple, Rigid Linkers
Anthony P Silvestri1, Philip A Cistrone1, Philip E Dawson1
1Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA, 92037, USA.
Angewandte Chemie (International Ed. in English)
|July 8, 2017
Summary
This study introduces a novel method for copper-catalyzed Glaser coupling, protecting peptides from oxidative damage. This breakthrough enables efficient conjugation of labels to complex molecules in aqueous solutions.
Area of Science:
- Organic Chemistry
- Bioconjugation Chemistry
- Catalysis
Background:
- Copper-mediated Glaser coupling forms rigid 1,3-diyne linkages.
- Simultaneous Cu(I) and oxidant requirements limit its use with sensitive molecules in water.
Purpose of the Study:
- To develop a robust Glaser coupling method for unprotected peptides in aqueous solution.
- To overcome Cu(II)-mediated oxidative degradation of complex substrates.
Main Methods:
- Utilized a specific bpy-diol ligand to protect unprotected peptides.
- Formed an insoluble Cu(II) gel to prevent substrate damage.
- Applied the method for conjugating labels to a GLP-1R agonist.
Main Results:
- The bpy-diol ligand effectively protected peptides from oxidative damage.
- The insoluble Cu(II) gel formation prevented degradation of sensitive substrates.
- Successful conjugation of diverse labels onto an unprotected GLP-1R agonist was achieved.
Conclusions:
- Developed a novel, protective strategy for copper-catalyzed Glaser coupling in aqueous media.
- Enabled bioconjugation of complex peptides and labeling of a GLP-1R agonist.
- Expanded the utility of Glaser coupling for functional molecules and drug discovery.
Related Concept Videos
Phase II Conjugation Reactions: Overview
1.0K
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
1.0K
Ligand Binding and Linkage
5.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.7K
Drug Metabolism: Phase II Reactions
5.3K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
5.3K

